checkAd

     122  0 Kommentare Pixium Vision announces attendance at upcoming conferences

    Pixium Vision announces attendance at upcoming conferences

    Paris, September 14th 2020 – 17.30 pm CET– Pixium Vision (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, today announces that management will attend and present at the following upcoming conferences:

          ·HC Wainwright & Co. 22nd Annual Global Investment Conference: Virtual Conference
                Mixed physical (New York) and digital event, September 14th to 16th
                Pixium Vision to present on Wednesday 16th September at 3:30pm ET (9.30 p.m. CET)
                 
          ·LSX’s Healthtech Leaders: Virtual Partnering and Investment
                Digital event, September 15th to 18th
                Pixium Vision to present on Tuesday 15th September at 9:00am BST (10.00 a.m. CET) in Company Showcase session
                 
          ·Lyon- les Rendez-vous mensuels de Lyon Pôle Bourse
                Physical event, October 6th from 5.00pm to 7.00pm CET in Lyon (France)
                Lloyd Diamond to present the Company at 6pm and answer questions in a Q&A session
                 
          ·MedTech Strategist Investment & Partnering Summit 2020
                Digital event, October 15th to November 20th on-demand
                One-to-one meetings
                 
          ·NEXT French Healthcare 2020
                Virtual business roadshow, October 13th to 23rd
                One-to-one meetings

    Seite 1 von 3



    Diskutieren Sie über die enthaltenen Werte



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Pixium Vision announces attendance at upcoming conferences Pixium Vision announces attendance at upcoming conferences Paris, September 14th 2020 – 17.30 pm CET– Pixium Vision (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients …